Announced Mon, 18 May · 16:50 IST

Update with regard to our intimation dated May 18, 2026 regarding movement in Board of Directors, KMP and SMP of the Company

Kmp ResignedPromoter Family Board EntryManagement Changes View source PDF

STAR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.6%1-day move
₹1105.00
prior close
₹1124.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-5.7-6.8-7.1-3.7+3.6+5.3+3.5+7.2+5.4+2.3-11.6+1.2-4.5
Up moveDown movePending
AI summary

Strides Pharma Science announced board and management changes effective June 1, 2026. Mr. Ramaraju PVS (currently COO) has been elevated to Executive Director and KMP, moving from SMP. Mr. Aditya Arun Kumar stepped down as Executive Director – Business Development and KMP, redesignated as Non-Executive Director. Aditya, son of Founder & Chairperson Arun Kumar and part of the promoter group, stated the change aligns with promoters' intention to professionalize management. Two new SMPs were added: Ms. Nandini Matiyani (Executive VP – HR) and Mr. Ariff Khan (Executive VP – Manufacturing Operations). The changes are subject to shareholder approval.

Likely market impact

These changes reflect management professionalization efforts with an internal promotion to board level and an internal executive transitioning to oversight role. Minor governance signal as a promoter family member moves from executive to non-executive board position.